English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Trial shows mavacamten benefits adolescents with obstructive heart condition

+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Higher sugar intake linked to increased gallstone risk in US adults, study finds

+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Trial finds no benefit from heart pump during angioplasty for severe heart failure patients

+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Study finds chronic colitis leaves stem cell changes that may raise cancer risk

+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Sotatercept shows improvement for patients with CpcPH-HFpEF in phase 2 trial

+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Noninvasive lung monitoring device reduces hospitalizations and deaths in HFpEF patients

+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Eli Lilly announces expanded partnership with Insilico Medicine in AI drug development deal

+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Biogen’s lupus drug shows reduced disease activity in mid-stage trial results

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'

+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes

  • « First
  • «
  • …
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily